Part: 12         Session: 145678910111213141516171819202122         Page 500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545 of 999

you some charts showing the state of

Are these taken from your new big book?

No, they're more advanced than that. We're going to update a few figures. But taken so long. They've taken nearly a year to talk about bringing it out, and now they're talking about bringing it out in late fall. Isn't that pestiferous?

This is McCann?

McKay. But the net of the advances: in hreast cancer, in women who have had extensions to four nodes under their arm, that type of operation -- those women have a 43% chance of a recurrence in the first year. And with a combination of drugs called cytoan, methotrexate and S-F-U, the recurrence rate, instead of being 43% is only 7%. However, the drugs are toxic. It does, however, show that you can prevent the recurrence of a cancer that's spread if you do it promptly after an operation when the tumor load is low. And in the past the doctors on the whole always gave chemotherapy after the tumor had recurred instead of giving it after it had been taken out and preventing its recurrence. Once it had recurred and people were practically dying, then they would be willing to give chemotherapy, which was then toxic and seldom saved lives. Now the other idea has suddenly come into being,